Guangdong Hybribio Biotech Co.,Ltd. (SHE:300639)
6.38
+0.03 (0.47%)
May 19, 2026, 10:15 AM CST
SHE:300639 Market Cap
SHE:300639 has a market cap or net worth of 3.99 billion as of May 18, 2026. Its market cap has increased by 24.56% in one year.
Market Cap
3.99B
Enterprise Value
3.04B
Revenue
669.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.38
Market Cap Chart
Since April 12, 2017, SHE:300639's market cap has increased from 2.38B to 3.99B, an increase of 67.23%. That is a compound annual growth rate of 5.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 3.99B | 18.03% |
| Dec 31, 2025 | 3.38B | -10.48% |
| Dec 31, 2024 | 3.77B | -37.03% |
| Dec 29, 2023 | 5.99B | -18.63% |
| Dec 30, 2022 | 7.36B | -14.35% |
| Dec 31, 2021 | 8.59B | -2.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 12, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amoy Diagnostics | 7.83B |
| Beijing Strong Biotechnologies,Inc. | 7.64B |
| Maccura Biotechnology Co.Ltd | 6.25B |
| Cowealth Medical China | 5.76B |
| Thalys Medical Technology Group | 4.47B |
| Shanghai Labway Clinical Laboratory | 4.24B |
| Medicalsystem Biotechnology | 3.85B |
| SMO ClinPlus CO.,LTD. | 3.82B |